| 000 | 01858 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514164016.0 | ||
| 264 | 0 | _c20040311 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a0007-0963 | ||
| 024 | 7 |
_a10.1111/j.1365-2133.2003.05600.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHorn, M | |
| 245 | 0 | 0 |
_aTopical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _cDec 2003 |
||
| 300 |
_a1242-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAminolevulinic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Basal Cell _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPhotochemotherapy |
| 650 | 0 | 4 |
_aPhotosensitizing Agents _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aSkin Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aWolf, P | |
| 700 | 1 | _aWulf, H C | |
| 700 | 1 | _aWarloe, T | |
| 700 | 1 | _aFritsch, C | |
| 700 | 1 | _aRhodes, L E | |
| 700 | 1 | _aKaufmann, R | |
| 700 | 1 | _aDe Rie, M | |
| 700 | 1 | _aLegat, F J | |
| 700 | 1 | _aStender, I M | |
| 700 | 1 | _aSolér, A M | |
| 700 | 1 | _aWennberg, A-M | |
| 700 | 1 | _aWong, G A E | |
| 700 | 1 | _aLarkö, O | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 149 _gno. 6 _gp. 1242-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2133.2003.05600.x _zAvailable from publisher's website |
| 999 |
_c14407404 _d14407404 |
||